009420.KS

Hanall Biopharma Co.,Ltd [009420.KS] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

009420.KS Stock Summary

Top 10 Correlated ETFs

009420.KS

Top 10 Correlated Stocks

009420.KS

In the News

009420.KS Financial details

Company Rating
-
Market Cap
1733.7B
Income
3.51B
Revenue
134.91B
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
306
Optionable
No
Shortable
Yes
Earnings
26 Apr 2024
P/E
308.27
Forward P/E
-
PEG
2.37
P/S
15.25
P/B
9.43
P/C
-
P/FCF
93.38
Quick Ratio
-
Current Ratio
3.82
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
69.22
EPS next Y
-
EPS next Q
-
EPS this Y
1298.18%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-28.66%
Revenue last 5Y
4.46%
Revenue Q/Q
-3.79%
EPS Q/Q
-997.93%
-
-
-
-
SMA20
-8.86%
SMA50
24%
SMA100
55.1%
Inst Own
-
Inst Trans
-
ROA
3%
ROE
3%
ROC
0.03%
Gross Margin
59%
Oper. Margin
5%
Profit Margin
5%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
18400.0-46750.0
52W High
-6.42%
52W Low
+137.77%
RSI
48.23
Rel Volume
0.38
Avg Volume
656.7K
Volume
251.83K
Perf Week
4.29%
Perf Month
-5.41%
Perf Quarter
71.57%
Perf Half Y
80.41%
-
-
-
-
Beta
0.859
-
-
Volatility
623.27%, 4099.12%
Prev Close
-0.57%
Price
43750
Change
3.31%

Something similar

Top by Market Cap
BRH.DE
FXAIX
1YD.DE
BRK-B
AMZN
Top Correlated ETFs
300640.KS
300610.KS
295020.KS
233160.KS
232080.KS
Top Correlated Stocks
1310.TW
293940.KS
112040.KQ
086900.KQ
1402.TW
Similar Market Cap
33637K.KS
7701.T
2801.T
204270.KQ
VTSAX

Company Profile

Healthcare Drug Manufacturers - Specialty & Generic
  • Volume Average 656.7K
  • Market Capitalization 1733.7B
  • Employee 306
  • CEO Sean Jeong
  • Headquarters Seoul,KR
  • IPO Date 2000-01-04
  • Website https://www.hanall.co.kr

Hanall Biopharma Co.,Ltd, a pharmaceutical company, researches, develops, and sells pharmaceutical products in South Korea and internationally. The company offers specialty drugs and over-the-counter products for the treatment of gastric and duodenal ulcers, gastritis, cerebrovascular and peripheral blood vessel disorder, hypertension, atherosclerotic symptom, acute coronary syndrome, atherothrombosis and thromboembolism, diabetes, osteoporosis, chronic kidney failure, hypothyroidism, vitamin D-resistant rickets, osteomalacia, erectile dysfunction, prostatic hyperplasia, candidiasis, various fungal infections, prostate cancer, formal, constipation, thin stools, bloating, bowel abnormal fermentation, and hemorrhoids. The company was founded in 1973 and is based in Seoul, South Korea.